|
|
|
Volumn 18, Issue 1, 1999, Pages 65-76
|
|
HMG-CoA reductase inhibitors: A brief review of their pharmacological properties and efficacy in cardiovascular disease;Inibidores da redutase da HMG-CoA: Breve revisao das suas propriedades farmacologicas e eficacia clinica na doenca cardiovascular
|
|
Author keywords
Atherosclerosis; Coronary heart disease; HMG CoA reductase; Statins; Therapeutics
|
|
Indexed keywords
APOLIPOPROTEIN B;
APOLIPOPROTEIN E;
ATORVASTATIN;
CERIVASTATIN;
CHOLESTEROL;
FLUINDOSTATIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LIPID;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEVINOLIN;
PRAVASTATIN;
SIMVASTATIN;
VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
DRUG MECHANISM;
GASTROINTESTINAL TOXICITY;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERLIPIDEMIA;
LIVER DYSFUNCTION;
MAJOR CLINICAL STUDY;
MYOPATHY;
PHARMACODYNAMICS;
PHARMACOKINETICS;
PRIMARY PREVENTION;
REVIEW;
SECONDARY PREVENTION;
CEREBROVASCULAR DISORDERS;
CHOLESTEROL;
HEART DISEASES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LIPOPROTEINS;
META-ANALYSIS;
|
|
EID: 0033007420
PISSN: 08702551
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (66)
|
